Skip to main content

Table 1 Comparison of the baseline clinical characteristics among patients

From: A sex-stratified long-term clinical outcome analysis in coronary chronic total occlusion patients

 

Total (n = 563)

Men (n = 456)

Women (n = 107)

p

Age (mean ± SD), years

64.7 ± 10.5

63.6 ± 10.6

69.5 ± 8.7

< 0.001

Hospitalization days

7 (5, 9)

7 (5, 8)

7 (5, 9)

0.425

BMI (mean ± SD), kg/m2

26.03 ± 3.42

26.19 ± 3.42

25.35 ± 3.35

0.022

AC (mean ± SD), cm

93.51 ± 9.86

94.3 ± 9.64

90.07 ± 10.11

< 0.001

Smoke

371 (65.9)

349 (76.5)

22 (20.6)

< 0.001

Drink

113 (20.1)

112 (24.6)

1 (0.9)

< 0.001

Hypertension

413 (73.4)

321 (70.4)

92 (86)

0.001

Diabetes mellitus

259 (46)

190 (41.7)

69 (64.5)

< 0.001

Hyperlipidemia

319 (56.7)

255 (55.9)

64 (59.8)

0.465

CAD

344 (61.1)

267 (58.6)

77 (72)

0.01

Previous MI

126 (22.4)

98 (21.5)

28 (26.2)

0.296

Heart failure

8 (1.4)

5 (1.1)

3 (2.8)

0.179

Chronic kidney disease

34 (6)

26 (5.7)

8 (7.5)

0.488

Peripheral vascular disease

42 (7.5)

32 (7)

10 (9.3)

0.409

Stroke

121 (21.5)

92 (20.2)

29 (27.1)

0.116

History of PCI

176 (31.3)

141 (30.9)

35 (32.7)

0.719

History of CABG

23 (4.1)

21 (4.6)

2 (1.9)

0.198

CHOL(mmol/L)

4.02 ± 106

3.96 ± 1.04

4.32 ± 1.11

0.002

LDL-C(mmol/L)

2.28 ± 0.75

2.24 ± 0.73

2.42 ± 0.79

0.028

eGFR(ml/min)

83.4 ± 22.11

84.68 ± 21.56

77.95 ± 23.67

0.005

NT-proBNPmax (pg/ml)

370 (106.5, 1337.5)

328 (94.53, 1196.75)

582 (135.5, 2152.5)

0.044

  1. Values are n (%), mean ± SD, or median with interquartile range
  2. AC abdominal circumference, CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CHOL cholesterol, LDL-c low-density lipoprotein cholesterol, NT-proBNP N-terminal pro-brain natriuretic peptide, eGFR estimated glomerular filtration rate